Current Drug Development Projects

This is a preview of the Data Table. Only the first three rows are displayed.
Title Disorder PI/Lead Investigator Institution
Developing nonmuscle II inhibitors for substance use relapse/a> Substance Use Disorder Miller, Courtney A Scripps Florida
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief Pain Katritch, Vsevolod University of Southern California
Small Molecule Mitochondria-Targeted Therapeutics for AD Alzheimers Disease Trushina, Eugenia Mayo Clinic Rochester
Developing a kinase inhibitor drug to treat spinal cord injury Spinal Cord Injury Al-Ali, Hassan University of Miami School of Medicine
Development of selective cannabinoid receptor 2 agonists for treatment of addiction Substance Use Disorder Shamloo, Mehrdad Stanford University
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits Cognitive Impairment Post-Seizure Ganesh, Thota Emory University
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics Pain Florio, Stephanie K Anagin